GlassScriptPhysician profile
Pedro E Mendez
NPI 1780610568
$14,436.33
in general payments reported to CMS, 2019-2025
92 companies · $3,256 in 2025
The $3,256 reported for 2025 was more than what 75% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.99 · 2021: $1,002 · 2022: $3,254 · 2023: $3,543 · 2024: $3,281 · 2025: $3,256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,872 · Education: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,872.21 |
| Education | $208.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,067.02 | 2022-2025 | Enhertu, Imfinzi, Calquence |
| Pfizer INC. | $879.37 | 2022-2025 | |
| Eisai INC. | $763.35 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $737.17 | 2021-2025 | |
| Janssen Biotech, INC. | $690.56 | 2019-2025 | Erleada, Darzalex, Rybrevant |
| Lilly USA, LLC | $634.83 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Exelixis INC. | $616.85 | 2021-2025 | Cabometyx |
| Daiichi Sankyo INC. | $613.60 | 2021-2025 | Enhertu, Injectafer, Datroway |
| Incyte Corporation | $602.89 | 2021-2025 | Jakafi, Monjuvi, Zynyz |
| Merck Sharp & Dohme LLC | $562.10 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Celgene Corporation | $527.94 | 2021-2025 | Reblozyl, Pomalyst, Breyanzi |
| Seagen INC. | $329.04 | 2021-2023 | Adcetris, Tivdak, Tukysa |
| Regeneron Healthcare Solutions, INC. | $312.50 | 2022-2025 | Libtayo, Lynozyfic |
| Beigene USA, INC. | $291.64 | 2021-2025 | Brukinsa, Tevimbra |
| Astellas Pharma US INC | $279.40 | 2021-2025 | Padcev, Xospata, Vyloy |
Show all 92 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $244.17 | 2021-2025 | Ojjaara, Jemperli, Zejula |
| Genzyme Corporation | $230.25 | 2021-2025 | |
| Array Biopharma INC | $218.88 | 2022-2025 | Braftovi, Lorbrena, Mektovi |
| Takeda Pharmaceuticals U.S.A., INC. | $218.35 | 2022-2025 | Iclusig, Ninlaro, Fruzaqla |
| Kite Pharma, INC. | $212.56 | 2021-2025 | Yescarta |
| Sobi, INC | $187.62 | 2022-2023 | |
| Abbvie INC. | $187.43 | 2024-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $168.53 | 2022-2023 | Imbruvica |
| Emd Serono, INC. | $161.06 | 2023-2025 | Bavencio |
| Pharmacosmos Therapeutics INC. | $157.61 | 2021-2025 | Monoferric, Cosela |
| Jazz Pharmaceuticals INC. | $146.29 | 2021-2025 | |
| Pharmaessentia USA Corporation | $136.11 | 2023-2025 | Besremi |
| Rigel Pharmaceuticals, INC. | $130.44 | 2022-2024 | Rezlidhia, Tavalisse |
| Karyopharm Therapeutics INC. | $127.95 | 2022-2025 | Xpovio |
| Tempus Ai, INC | $109.12 | 2024-2025 | Xt Cdx |
| Aveo Pharmaceuticals, INC. | $107.98 | 2021-2025 | Fotivda |
| Sumitomo Pharma America, INC. | $105.97 | 2023-2025 | Orgovyx |
| Tersera Therapeutics LLC | $98.25 | 2022-2023 | Quzyttir, Zoladex |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.99 | 2021-2022 | |
| Agios Pharmaceuticals, INC. | $93.37 | 2023-2025 | Pyrukynd |
| Adc Therapeutics America, INC. | $89.45 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.97 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $81.67 | 2022-2025 | Ultomiris |
| Acrotech Biopharma INC. | $80.28 | 2022-2024 | Ryzneuta |
| Amgen INC. | $78.36 | 2022 | |
| Kyowa Kirin, INC. | $77.74 | 2024-2025 | Poteligeo |
| Morphosys, US INC. | $76.90 | 2022-2023 | Monjuvi |
| Blueprint Medicines Corporation | $73.90 | 2023-2024 | Ayvakit |
| Servier Pharmaceuticals LLC | $69.56 | 2022-2025 | |
| Menarini Silicon Biosystems, INC. | $69.45 | 2023 | Cellsearch |
| Novocure INC. | $67.72 | 2025 | Optune Lua (Novottf-200t), Optune Gio |
| Sun Pharmaceutical Industries INC. | $63.36 | 2022-2024 | |
| Macrogenics, INC. | $58.72 | 2021-2023 | |
| Beone Medicines USA, INC. | $57.33 | 2025 | Brukinsa |
| Stemline Therapeutics INC. | $55.48 | 2023 | Orserdu |
| Puma Biotechnology, INC. | $54.51 | 2022-2025 | |
| Gt Medical Technologies, INC | $52.08 | 2022-2023 | Gammatile |
| Gilead Sciences, INC. | $49.99 | 2021-2022 | |
| Global Blood Therapeutics, INC. | $47.90 | 2022 | |
| Deciphera Pharmaceuticals INC. | $47.53 | 2021-2023 | Qinlock |
| Ge Healthcare | $46.98 | 2021-2022 | |
| Mirati Therapeutics, INC. | $43.75 | 2023-2024 | Krazati |
| Recordati_rare_diseases_inc. | $43.14 | 2023-2025 | Panhematin, Sylvant |
| Amneal Pharmaceuticals LLC | $41.20 | 2023-2024 | Avastin, Neulasta, Neupogen |
| Catalyst Pharmaceuticals, INC. | $38.93 | 2024 | |
| Janssen Scientific Affairs, LLC | $37.70 | 2025 | Imbruvica, Tecvayli, Carvykti |
| Tg Therapeutics, INC. | $36.57 | 2021-2022 | |
| Genentech USA, INC. | $36.50 | 2021-2022 | |
| Legend Biotech USA INC. | $36.35 | 2025 | Carvykti |
| G1 Therapeutics, INC. | $36.29 | 2022-2023 | Cosela |
| Taiho Oncology, INC. | $35.85 | 2022-2025 | |
| Myovant Sciences INC. | $35.55 | 2021-2022 | |
| Adaptive Biotechnologies Corporation | $35.41 | 2022 | |
| Sirtex Medical INC | $32.46 | 2023 | Sir-Spheres Microspheres |
| Azurity Pharmaceuticals, INC. | $32.23 | 2025 | Danziten |
| Caris Mpi, INC. | $30.36 | 2025 | Mi Cancer Seek |
| Secura Bio, INC. | $28.11 | 2021-2024 | Copiktra |
| Springworks Therapeutics, INC. | $27.83 | 2024 | Ogsiveo |
| Iovance Biotherapeutics, INC. | $27.68 | 2025 | Amtagvi |
| E.R. Squibb & Sons, L.L.C. | $25.65 | 2023 | Opdualag |
| Dendreon Pharmaceuticals LLC | $24.76 | 2025 | Provenge |
| Csl Behring | $24.43 | 2022 | |
| Telix Pharmaceuticals | $24.12 | 2024 | Illuccix |
| Fennec Pharmaceuticals, INC. | $24.05 | 2024 | Pedmark |
| Fresenius Kabi USA, LLC | $23.57 | 2025 | Stimufend |
| Ipsen Biopharmaceuticals, INC | $22.28 | 2024 | Onivyde |
| Shield Therapeutics INC | $21.97 | 2025 | |
| Spectrum Pharmaceuticals INC. | $21.31 | 2025 | Rolvedon |
| Eusa Pharma (US) LLC | $20.72 | 2022 | |
| Immunogen, INC. | $20.59 | 2023 | Elahere |
| Apellis Pharmaceuticals, INC. | $20.08 | 2022 | |
| Tolmar, INC. | $17.37 | 2025 | Rubraca |
| Pharmaand Gmbh | $17.37 | 2025 | Rubraca |
| Heron Therapeutics, INC. | $17.34 | 2021 | |
| Epizyme, INC. | $16.60 | 2022 | |
| Dova Pharmaceuticals | $16.44 | 2021 | |
| Accord Healthcare, INC. | $12.70 | 2023 |
Drugs and devices associated with these payments
Enhertu $674Lenvima $532Keytruda $439Cabometyx $363Verzenio $330Jaypirca $297Adcetris $258Imbruvica $251Lynparza $247Brukinsa $241Reblozyl $240Libtayo $228Ibrance $224Monjuvi $205Jakafi $193Imfinzi $186Calquence $184Elrexfio $172Braftovi $172Retevmo $169Pomalyst $167Bosulif $164Yescarta $159Lorbrena $155Pluvicto $154Tukysa $149Ojjaara $147Erleada $144Besremi $136Darzalex $131Doptelet $126Ayvakit $124Padcev $122Scemblix $120Mektovi $113Xpovio $112Xtandi $110Xt Cdx $109Orgovyx $106Kisqali $99.98Pyrukynd $93.37Rybrevant $93.20Comirnaty $91.10Akeega $90.00Inlyta $85.55Tavalisse $85.36Rezlidhia $85.36Monoferric $85.21Tecvayli $84.32Zepzelca $81.62Poteligeo $77.74Besponsa $76.88Carvykti $74.05Paxlovid $69.54Cellsearch $69.45Talzenna $68.38Oxbryta $63.40Promacta $58.74Welireg $57.96Fotivda $56.07Orserdu $55.48Venclexta $53.98Tivdak $52.74Injectafer $52.58Iclusig $49.09Elahere $48.44Illuccix $48.24Ninlaro $48.01Zejula $45.40Jemperli $45.40Piqray $44.34Stivarga $44.21Nubeqa $44.21Vitrakvi $44.21Krazati $43.75Ryzneuta $43.40Epkinly $42.85Ultomiris $42.69Bavencio $41.81Cosela $41.64Avastin $41.20Firdapse $38.93Agamree $38.93Talvey $37.70Optune Lua (Novottf-200t) $37.17Fruzaqla $35.00Rubraca $34.74Lynozyfic $34.64Xospata $33.67Quzyttir $33.13Sir-Spheres Microspheres $32.46Danziten $32.23Vyloy $32.15Fabhalta $31.77Shingrix $30.98Alunbrig $30.88Yonsa $30.79Odomzo $30.79Optune Gio $30.55Mi Cancer Seek $30.36
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pedro Mendez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.